JPRN-UMIN000028989
Completed
Phase 4
Prospective observational study on the key drug selection in advanced/recurrent EGFR mutation-positive non-small-cell lung cancer - Prospective observational study on the key drug selection in advanced/recurrent EGFR mutation-positive non-small-cell lung cancer
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Osaka International Cancer Institute
- Enrollment
- 524
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients judged by the investigator to be unsuitable for the study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Prospective study to assess the emergence of drug resistance to oseltamivir following treatment of acute influenza A among children - Oseltamivir resistance studyInfluenza AEUCTR2005-005239-80-GBniversity Hospitals Leicester, Leicester General Hospital100
Completed
Not Applicable
A clinical study for evaluating the efficacy of seasoning containing functional ingredients on the suppression of the elevation of postprandial serum triglyceride. (Randomised, placebo controlled crossover study)Healthy adultJPRN-UMIN000027767CPCC Company, Limited16
Not yet recruiting
Not Applicable
Profile of adverse drug reaction in children suffering from cancer in a hospital settingCTRI/2023/11/059711Government Medical College Jammu
Not yet recruiting
Not Applicable
Study comparing anti-tuberculosis drug levels in saliva, plasma, and urine in patientsACTRN12623001088639Western Sydney Local Health District30
Completed
Phase 2
effect of Sovodak in patients with hepatitis C and HIV-1Condition 1: Hepatitis C and HIV. Condition 2: Human immunodeficiency virus.Acute hepatitis CHuman immunodeficiency virus [HIV] diseaseIRCT20180924041107N1Tabriz University of Medical Sciences22